This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
When To Switch From Target Date Fund To Age Based Approach: Go. This intro covers when a switch makes sense and what signals to watch for in your plan.
25,368 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Radian Group confirms it will wind down its mortgage conduit business following a divestiture review, while continuin...
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Oil sits near $102 per barrel in mid-March 2026 as markets digest supply discipline, demand recovery, and policy move...
General Mills faces a turning point in 2026. This in-depth look examines earnings drivers, margins, and cash returns,...
Forecasts point to a higher 2027 social security cola as energy prices climb, potentially boosting benefits but signa...
A year after GameStop added bitcoin to its treasury, the company reports a sizable impairment on digital assets amid ...
A 130-day tenure ends as the white house crypto czar departs, leaving a policy footprint that favors banks and infras...
Gladstone Investment faces a quarterly miss that pressures its 5.7% yield, spotlighting the risks and resilience of a...
President Donald Trump plans up to four in-person talks with Xi Jinping within eight months as Air Force One heads to...
With rates steady and mobility rising, financial advisors contend that the decision to rent or buy depends on your li...
Patience and big-capital bets define Iren's path. This analysis explains why Iren's earnings highlight long-term grow...